Prothena Corporation plc (NASDAQ: PRTA) has experienced a decline in its stock price by -7.02 compared to its previous closing price of 15.81. However, the company has seen a fall of -5.04% in its stock price over the last five trading days. businesswire.com reported 2024-12-30 that DUBLIN–(BUSINESS WIRE)—- $PRTA #prothena–Prothena announced that Oleg Nodelman will step down from Prothena’s Board of Directors to create time to focus on existing and new endeavors.
Is It Worth Investing in Prothena Corporation plc (NASDAQ: PRTA) Right Now?
Additionally, the 36-month beta value for PRTA is 0.09. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 3 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for PRTA is 44.79M and currently, short sellers hold a 20.87% ratio of that float. The average trading volume of PRTA on January 31, 2025 was 543.96K shares.
PRTA’s Market Performance
PRTA stock saw a decrease of -5.04% in the past week, with a monthly decline of -2.91% and a quarterly a decrease of -16.43%. The volatility ratio for the week is 6.52%, and the volatility levels for the last 30 days are 7.36% for Prothena Corporation plc (PRTA). The simple moving average for the past 20 days is 3.50% for PRTA’s stock, with a -22.27% simple moving average for the past 200 days.
Analysts’ Opinion of PRTA
Many brokerage firms have already submitted their reports for PRTA stocks, with Chardan Capital Markets repeating the rating for PRTA by listing it as a “Buy.” The predicted price for PRTA in the upcoming period, according to Chardan Capital Markets is $40 based on the research report published on December 20, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see PRTA reach a price target of $38, previously predicting the price at $68. The rating they have provided for PRTA stocks is “Neutral” according to the report published on January 30th, 2024.
Deutsche Bank gave a rating of “Buy” to PRTA, setting the target price at $62 in the report published on December 12th of the previous year.
PRTA Trading at 2.21% from the 50-Day Moving Average
After a stumble in the market that brought PRTA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.44% of loss for the given period.
Volatility was left at 7.36%, however, over the last 30 days, the volatility rate increased by 6.52%, as shares sank -1.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.70% lower at present.
During the last 5 trading sessions, PRTA fell by -5.04%, which changed the moving average for the period of 200-days by -33.90% in comparison to the 20-day moving average, which settled at $14.20. In addition, Prothena Corporation plc saw 6.14% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for PRTA
Current profitability levels for the company are sitting at:
- -1.26 for the present operating margin
- 0.45 for the gross margin
The net margin for Prothena Corporation plc stands at -0.99. The total capital return value is set at -0.31. Equity return is now at value -22.90, with -19.64 for asset returns.
Based on Prothena Corporation plc (PRTA), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -13.32. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -25.68.
Currently, EBITDA for the company is -190.11 million with net debt to EBITDA at 3.19. When we switch over and look at the enterprise to sales, we see a ratio of 2.12. The liquidity ratio also appears to be rather interesting for investors as it stands at 11.52.
Conclusion
In conclusion, Prothena Corporation plc (PRTA) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
